在天气之下:2023年6月,莱斯特发生了一场流行性雷暴喘事件
Sarah Diver1,2, Fiona Symon3, Jack Satchwell3,4
1Department of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, UK sed22@le.ac.uk.
BMJ open respiratory research
|April 18, 2025
概括
气候变化加剧的雷暴喘事件构成越来越大的风险. 识别像Cladosporium子这样的触发因素,改善吸入疗法的准入,可以帮助预防未来的流行病.
科学领域:
- 环境健康 环境健康
- 流行病学 流行病学
- 过敏 免疫学 免疫学
背景情况:
- 气候变化和人口增长正在增加雷暴喘的威胁.
- 流行性雷暴喘事件是不可预测的,并具有严重的后果.
- 需要新的研究方法来了解风险因素和开发干预措施.
研究的目的:
- 为了提供雷暴喘的概述.
- 为了描述2023年6月英国的流行病.
- 确定雷暴喘的关键调解者和危险因素.
主要方法:
- 雷暴喘的审查.雷暴喘的审查.
- 在英国莱斯特的一个特定流行病的分析.
- 鉴定真菌子 (Cladosporium) 作为潜在的触发因素.
主要成果:
- 克拉多斯波里亚子被确定为英国雷暴喘的关键因素.
- 在成年人中,背景治疗水平较低,在儿童中增加了紧急评估.
- 在活动期间,儿童住院病例并没有显著增加.
结论:
- 提高公众意识和获得标准的吸入疗法,可以预防雷暴喘流行病.
- 需要进一步的研究,以尽量减少雷暴喘的不良影响.
- 识别面临风险的人群和时间对于干预开发至关重要.
相关概念视频
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
231
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
231
Antiasthma Drugs: Leukotriene Modifiers
150
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
150
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


